
Home » Roche’s Gazyva Gives Leukemia Patients Extra Year Over Rituxan
Roche’s Gazyva Gives Leukemia Patients Extra Year Over Rituxan
November 7, 2013
In a clinical trial, Roche’s Gazyva added almost a year to the lives of patients with chronic lymphocytic leukemia.
BusinessWeek
BusinessWeek
Upcoming Events
-
15Apr
-
21Apr
-
26Apr
-
06May